Pradaxa

dabigatran etexilate · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

103 regulatory and trial events tracked for Pradaxa, covering 2010-10-19 to 2026-03-13. Get the full timeline:

Most recent: EMA Authorised: Pradaxa (dabigatran etexilate mesilate) — Boehringer Ingelheim International GmbH